Santiago Federico Coroleu1, MD; Maria De Vita2, MD, PhD; Francesco Burzotta1*, MD, PhD; Carlo Trani1, MD; Italo Porto1, MD, PhD; Giampaolo Niccoli1, MD, PhD; Antonio Maria Leone1, MD, PhD; Antonella Tommasino1, MD; Giovanni Paolo Talarico1, MD; Giovanni Schiavoni1, MD; Filippo Crea1, MD
1. Institute of Cardiology, Catholic University of Sacred Heart, Rome, Italy; 2. Cardiology Department, Morgagni Hospital, Forli, Italy
Aims: Restenosis and bifurcated lesions represent technically challenging lesions for percutaneous coronary interventions (PCI). Data regarding